LiveActive security incident?Get immediate response
CVE Record

CVE-2020-14525: Philips Clinical Collaboration Platform Improper Neutralization of Script in Attributes in a Web Page

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.

LowCVSS 3.5Not KEV-listedUpdated
Glexia's TakeAutomated analysislow

Security readout for executives and security teams

Plain-English summary

This is a low-severity web input handling issue in Philips Clinical Collaboration Platform 12.2.1 and earlier. A logged-in nearby-network attacker could cause limited information disclosure through script placed in content later served to users. The provided sources do not show active exploitation.

Executive priority

Treat as a routine remediation item unless the affected platform is broadly accessible inside clinical networks. The expected impact is limited confidentiality exposure, not system takeover or service outage, based on the provided CVSS data.

Technical view

CVE-2020-14525 is CWE-83 improper neutralization of script in HTML attributes. CVSS 3.1 is 3.5: adjacent network, low complexity, low privileges, no user interaction, unchanged scope, low confidentiality impact only. Evidence names Philips Clinical Collaboration Platform 12.2.1 and prior.

Likely exposure

Exposure is most likely in healthcare environments running Philips Clinical Collaboration Platform version 12.2.1 or earlier, especially where authenticated users can submit data displayed in web pages for other users.

Exploitation context

CISA KEV status is false, and the supplied bundle contains no cited evidence of exploitation in the wild. The CVSS vector indicates access from an adjacent network and a low-privileged account would be required.

Researcher notes

The affected version data in the bundle is inconsistent: the narrative says 12.2.1 and prior, while the structured affected entry lists version "0" with default unaffected. Use the narrative and vendor advisories for scoping.

Mitigation direction

  • Inventory Philips Clinical Collaboration Platform deployments and identify versions 12.2.1 or earlier.
  • Review Philips and CISA advisories for vendor-approved remediation guidance.
  • Limit platform access to trusted clinical networks and authorized users.
  • Prioritize vendor-supported updates or compensating controls confirmed by Philips guidance.

Validation and detection

  • Confirm installed product name and version against Philips Clinical Collaboration Platform 12.2.1 and prior.
  • Review access paths for adjacent-network exposure and low-privileged user accounts.
  • Check application logs for unusual submitted content in fields rendered to other users.
  • Verify remediation status against Philips or CISA advisory instructions.
Prepared
Confidence
medium
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-83: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2020-14525 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Low
CVSS
3.5 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
3Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
3.5CVSS 3.1LowCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N2.11.4Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

3.5Low
CVSS 3.1 vector shape for CVE-2020-14525Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone
Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
PhilipsClinical Collaboration Platform0unaffected
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.